0 results available. Select is focused ,type to refine list, press Down to open the menu,
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally. The company offers Omnipod platform ...
The following section summarizes insights on Insulet Corporation's EBITDA Margin:
We've identified the following companies as similar to Insulet Corporation because they operate in a related industry or sector. We also considered size, growth, and various financial metrics to narrow down the list to the ones listed below.
To view the full list of supported financial metrics please see Complete Metrics Listing.
Metrics similar to EBITDA Margin in the efficiency category include:
Earnings before interest, taxes, depreciation and amortization (EBITDA) expressed as a percent of revenue.
The ebitda margin measures a company’s ebitda as a percentage of the revenue. The formula to calculate ebitda margin and an example calculation for Insulet’s trailing twelve months is outlined below:
EBITDA Margin = EBITDA / Total Revenue
18.8% = 389.7 M / 2.072 B
The tables below summarizes Insulet’s performance over the last five years:
| Fiscal Year | EBITDA | Revenue | Margin |
|---|---|---|---|
| 2020-12-31 | 106.9 M | 904.4 M | 11.8% |
| 2021-12-31 | 183.4 M | 1.099 B | 16.7% |
| 2022-12-31 | 120.8 M | 1.305 B | 9.3% |
| 2023-12-31 | 281.3 M | 1.697 B | 16.6% |
| 2024-12-31 | 389.7 M | 2.072 B | 18.8% |
The tables below summarizes Insulet’s performance over the last four quarters:
| Quarter Ending | EBITDA | Revenue | Margin |
|---|---|---|---|
| 2024-03-31 | 75.7 M | 441.7 M | 17.1% |
| 2024-06-30 | 73.8 M | 488.5 M | 15.1% |
| 2024-09-30 | 109.4 M | 543.9 M | 20.1% |
| 2024-12-31 | 117.3 M | 597.5 M | 19.6% |
You can read more about EBITDA here.
The chart above depicts the distribution of ebitda margin for companies operating in the Healthcare sector in the Developed economic region. Over 1,930 companies were considered in this analysis, and 1,854 had meaningful values. The average ebitda margin of companies in the sector is -1,018.9% with a standard deviation of 3,947.0%.
Insulet Corporation's EBITDA Margin of 18.8% ranks in the 83.8% percentile for the sector. The following table provides additional summary stats:
| Economic Risk Region | Developed |
| Total Constituents | 1,932 |
| Included Constituents | 1,854 |
| Min | -44,466.7% |
| Max | 54.4% |
| Median | -10.9% |
| Mean | -1,018.9% |
| Standard Deviation | 3,947.0% |
You can find companies with similar ebitda margin using this stock screener.